| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
251,510,000 |
| Market
Cap: |
136.22(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$414.13 - $543.89 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 17 |
| Guru Rank Value : 22.1 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
44,753 |
52,053 |
52,427 |
77,577 |
| Total Sell Value |
$23,062,766 |
$26,598,808 |
$26,775,666 |
$38,325,083 |
| Total People Sold |
4 |
6 |
7 |
8 |
| Total Sell Transactions |
5 |
8 |
10 |
15 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Haytaian Peter D |
EVP & President, GBD |
• • – |
2018-03-02 |
4 |
D |
$233.08 |
$2,039,683 |
D/D |
(8,751) |
43,902 |
|
- |
|
| Griffin Brian T |
EVP & President, CSBD |
• • – |
2018-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,462 |
15,863 |
|
- |
|
| Griffin Brian T |
EVP & President, CSBD |
• • – |
2018-03-02 |
4 |
D |
$233.08 |
$526,528 |
D/D |
(2,259) |
10,401 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2018-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
952 |
1,915 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2018-03-02 |
4 |
D |
$233.08 |
$71,089 |
D/D |
(305) |
963 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• • – |
2018-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,228 |
39,024 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• • – |
2018-03-02 |
4 |
D |
$233.08 |
$1,478,193 |
D/D |
(6,342) |
26,796 |
|
- |
|
| Swedish Joseph |
Executive Chairman |
• • – |
2018-03-01 |
4 |
D |
$232.04 |
$1,414,516 |
D/D |
(6,096) |
60,447 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,502 |
22,064 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• • – |
2018-03-01 |
4 |
D |
$232.04 |
$153,146 |
D/D |
(660) |
18,562 |
|
- |
|
| Zielinski Thomas C |
EVP & General Counsel |
• • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,694 |
19,338 |
|
- |
|
| Zielinski Thomas C |
EVP & General Counsel |
• • – |
2018-03-01 |
4 |
D |
$232.04 |
$185,632 |
D/D |
(800) |
16,644 |
|
- |
|
| Samitt Craig E |
EVP & Chief Clinical Officer |
• • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,694 |
11,011 |
|
- |
|
| Samitt Craig E |
EVP & Chief Clinical Officer |
• • – |
2018-03-01 |
4 |
D |
$232.04 |
$157,091 |
D/D |
(677) |
8,317 |
|
- |
|
| Haytaian Peter D |
EVP & President, GBD |
• • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,812 |
52,653 |
|
- |
|
| Haytaian Peter D |
EVP & President, GBD |
• • – |
2018-03-01 |
4 |
D |
$232.04 |
$279,608 |
D/D |
(1,205) |
44,841 |
|
- |
|
| Wolf Jacquelyn H |
EVP & Chief HR Officer |
• • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,155 |
3,105 |
|
- |
|
| Boudreaux Gail |
President and CEO |
• • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,044 |
11,044 |
|
- |
|
| Griffin Brian T |
EVP & President, CSBD |
• • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,502 |
12,660 |
|
- |
|
| Griffin Brian T |
EVP & President, CSBD |
• • – |
2018-03-01 |
4 |
D |
$232.04 |
$198,626 |
D/D |
(856) |
9,158 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
388 |
1,268 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2018-03-01 |
4 |
D |
$232.04 |
$29,005 |
D/D |
(125) |
880 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• • – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,502 |
33,138 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• • – |
2018-03-01 |
4 |
D |
$232.04 |
$216,029 |
D/D |
(931) |
29,636 |
|
- |
|
| Jallal Bahija |
Director |
• • – |
2018-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
204 |
204 |
|
- |
|
1950 Records found
|
|
Page 15 of 78 |
|
|
6.09 (1.11%) 
